Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
| Business Activity | PASS |
| Debt Ratio (0.26%) | PASS |
| Cash Ratio (0.01%) | PASS |
| Receivables Ratio (0.26%) | PASS |
| Revenue Ratio (0.01%) | PASS |
| Overall | PASS |
| Date | EPS Est. | Reported EPS | Surprise % |
|---|---|---|---|
| 2026-05-27 | 1.41 | Pending | -- |
| 2026-05-27 | 1.41 | 1.49 | +5.8% |
| 2026-02-25 | 1.24 | 1.07 | -13.7% |
| 2026-02-25 | 1.37 | 1.36 | -0.6% |
| 2025-11-24 | 1.58 | 1.59 | +0.4% |
| 2025-11-24 | 1.58 | 1.59 | +0.4% |
| 2025-08-27 | 1.37 | 1.37 | +0.2% |
| 2025-05-28 | 1.26 | 1.31 | +3.6% |
| Period | Revenue | Net Income | EBITDA | Gross Profit | Op. Income | EPS |
|---|---|---|---|---|---|---|
| 2026-01-31 | $1.8B | $305.0M | $456.0M | $946.0M | $353.0M | 1.08 |
| 2025-10-31 | $1.9B | $434.0M | $540.0M | $990.0M | $443.0M | 1.53 |
| 2025-07-31 | $1.7B | $336.0M | $466.0M | $888.0M | $360.0M | 1.18 |
| 2025-04-30 | $1.7B | $215.0M | $362.0M | $866.0M | $300.0M | 0.75 |
| 2025-01-31 | $1.7B | $318.0M | $467.0M | $899.0M | $376.0M | 1.12 |
| Date | Name | Role | Shares | Value |
|---|---|---|---|---|
| 2026-03-19 | ANAND MALA | Director | 2,158 | $241.2K |
| 2026-03-19 | BRAWLEY OTIS W | Director | 3,046 | $340.4K |
| 2026-03-19 | KOH BOON HWEE | Director | 2,158 | $241.2K |
| 2026-03-19 | PODOLSKY DANIEL K | Director | 2,158 | $241.2K |
| 2026-03-19 | SORIOT PASCAL | Director | 2,158 | $241.2K |
| 2026-03-19 | SCANGOS GEORGE A | Director | 3,215 | $359.3K |
| 2026-03-19 | WILSON DOW R | Director | 2,158 | $241.2K |
| 2026-03-19 | BROWN JUDY LYNNE GAWLIK | Director | 2,158 | $241.2K |
| 2026-03-19 | DOLSTEN MIKAEL G | Director | 2,158 | $241.2K |
| 2026-03-19 | RATAJ SUE H | Director | 2,158 | $241.2K |
| Holder | Shares | Value | % Held |
|---|---|---|---|
| Blackrock Inc. | 25.9M | $3.0B | 0.1% |
| Vanguard Capital Management LLC | 18.4M | $2.1B | 0.1% |
| Vanguard Portfolio Management LLC | 14.4M | $1.6B | 0.1% |
| State Street Corporation | 12.8M | $1.5B | 0.0% |
| Massachusetts Financial Services Co. | 12.6M | $1.5B | 0.0% |
| T. Rowe Price Investment Management, Inc. | 9.0M | $1.0B | 0.0% |
| Geode Capital Management, LLC | 7.5M | $864.7M | 0.0% |
| Wellington Management Group, LLP | 7.3M | $834.2M | 0.0% |
| Deutsche Bank AG | 6.0M | $687.9M | 0.0% |
| Morgan Stanley | 4.9M | $569.0M | 0.0% |
$34.3B
4.70
1.219
16
$7.1B
$3.6B
-3.6%
0.9%
1.59
2.64
0.0%
18,000
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| 2026-05-27 | $1.41 | Pending | — |
| 2026-05-27 | $1.41 | $1.49 | +5.8% |
| 2026-02-25 | $1.24 | $1.07 | -13.7% |
| 2026-02-25 | $1.37 | $1.36 | -0.6% |
| 2025-11-24 | $1.58 | $1.59 | +0.4% |
| 2025-11-24 | $1.58 | $1.59 | +0.4% |
| Shares | Cost | Profit to Target | R:R |
|---|---|---|---|
| To Consensus ($161.13, 15 analysts) | |||
| 10 | $1,120.30 | +$491.00 (44%) | 2.9R |
| 50 | $5,601.50 | +$2,455.00 (44%) | 2.9R |
| 100 | $11,203.00 | +$4,910.00 (44%) | 2.9R |
| To Fair Value ($78.99) | |||
| 10 | $1,120.30 | +$-330.40 (-29%) | -2.0R |
| 50 | $5,601.50 | +$-1,652.00 (-29%) | -2.0R |
| 100 | $11,203.00 | +$-3,304.00 (-29%) | -2.0R |
- No elevated risk flags in current data
A single score combining all analytical layers below. A is strongest, D is weakest.
How much could this ticker lose on a bad day? These metrics measure worst-case scenarios from historical data.
Based on 10,000 simulated price paths, here is the probability of where this ticker could be in 30, 60, and 90 days.
What direction is this ticker actually moving, filtered through noise? Is it speeding up or slowing down?
Classic chart signals that institutional traders monitor. Golden Cross is bullish, Death Cross is bearish.
Is this company financially sound? The Z-Score measures bankruptcy risk. The F-Score measures fundamental strength.
These tickers tend to move together (positive) or in opposite directions (negative). Useful for portfolio diversification.
| Ticker | Correlation |
|---|---|
| MTD | 0.779 |
| TMO | 0.749 |
| WAT | 0.748 |
| RVTY | 0.719 |
| DHR | 0.709 |
| Ticker | Correlation |
|---|---|
| SUKOON.AE | -0.162 |
| CME | -0.154 |
| KR | -0.151 |
| LPTVQ | -0.142 |
| 2269.T | -0.139 |
Does this ticker have consistent patterns on certain days or months? Historical tendencies, not guarantees.
After this company beats earnings, does the price keep going up? Drift tracks post-earnings momentum.
How does this ticker's recent performance compare to the entire universe? Ranked across 1, 3, 6, and 12-month returns.